Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aneuploidy | 12 | 2023 | 42 | 4.300 |
Why?
|
| Saccharomyces cerevisiae | 9 | 2025 | 564 | 2.590 |
Why?
|
| Sphingolipids | 4 | 2025 | 24 | 1.710 |
Why?
|
| Nuclear Envelope | 2 | 2025 | 49 | 1.550 |
Why?
|
| Down Syndrome | 2 | 2023 | 46 | 1.380 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2016 | 127 | 1.030 |
Why?
|
| Genomic Instability | 2 | 2025 | 55 | 1.020 |
Why?
|
| Cell Division | 2 | 2025 | 450 | 0.910 |
Why?
|
| Trisomy | 2 | 2023 | 21 | 0.890 |
Why?
|
| Gene Dosage | 4 | 2021 | 65 | 0.840 |
Why?
|
| Serine | 3 | 2022 | 91 | 0.760 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2025 | 445 | 0.610 |
Why?
|
| Fibroblasts | 1 | 2021 | 394 | 0.600 |
Why?
|
| Cell Proliferation | 5 | 2021 | 988 | 0.580 |
Why?
|
| Transcription, Genetic | 6 | 2021 | 878 | 0.520 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2025 | 17 | 0.430 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 263 | 0.390 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 770 | 0.350 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 3 | 2005 | 6 | 0.310 |
Why?
|
| Mitosis | 2 | 2025 | 218 | 0.310 |
Why?
|
| Up-Regulation | 2 | 2021 | 374 | 0.290 |
Why?
|
| Depression | 3 | 2025 | 894 | 0.270 |
Why?
|
| cdc42 GTP-Binding Protein | 2 | 2005 | 22 | 0.260 |
Why?
|
| Proteins | 3 | 2017 | 750 | 0.260 |
Why?
|
| Anxiety | 3 | 2025 | 425 | 0.250 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2005 | 7 | 0.250 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2157 | 0.240 |
Why?
|
| GTP Phosphohydrolases | 1 | 2005 | 60 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 200 | 0.230 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2024 | 1 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 126 | 0.230 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2024 | 14 | 0.230 |
Why?
|
| Humans | 17 | 2025 | 63511 | 0.220 |
Why?
|
| Sphingosine | 2 | 2022 | 19 | 0.210 |
Why?
|
| Sex Chromosomes | 1 | 2023 | 8 | 0.210 |
Why?
|
| Neoplasms | 4 | 2022 | 1364 | 0.210 |
Why?
|
| Proteolysis | 1 | 2024 | 145 | 0.210 |
Why?
|
| Chromosome Segregation | 1 | 2023 | 40 | 0.210 |
Why?
|
| Stress, Psychological | 2 | 2025 | 471 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.200 |
Why?
|
| Adaptation, Psychological | 1 | 2025 | 267 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2021 | 1537 | 0.190 |
Why?
|
| Students | 1 | 2025 | 218 | 0.190 |
Why?
|
| Macromolecular Substances | 2 | 2021 | 160 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2025 | 629 | 0.180 |
Why?
|
| Argentina | 4 | 2025 | 11 | 0.180 |
Why?
|
| Quarantine | 1 | 2020 | 11 | 0.170 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2024 | 219 | 0.160 |
Why?
|
| Karyotype | 1 | 2019 | 18 | 0.160 |
Why?
|
| Neurons | 1 | 2005 | 923 | 0.160 |
Why?
|
| Yeasts | 1 | 2019 | 49 | 0.160 |
Why?
|
| Cell Survival | 1 | 2021 | 575 | 0.150 |
Why?
|
| Lipids | 1 | 2021 | 315 | 0.140 |
Why?
|
| Ceramides | 1 | 2017 | 23 | 0.140 |
Why?
|
| Mucoproteins | 1 | 2017 | 4 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2024 | 126 | 0.140 |
Why?
|
| Mitochondria | 2 | 2017 | 372 | 0.140 |
Why?
|
| Mental Health | 1 | 2020 | 371 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 19 | 0.130 |
Why?
|
| Karyotyping | 1 | 2016 | 48 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 111 | 0.120 |
Why?
|
| Models, Biological | 3 | 2015 | 1180 | 0.120 |
Why?
|
| Lens, Crystalline | 1 | 2015 | 16 | 0.120 |
Why?
|
| RNA, Fungal | 1 | 2016 | 43 | 0.120 |
Why?
|
| Scattering, Radiation | 1 | 2015 | 73 | 0.120 |
Why?
|
| Animals | 7 | 2017 | 20666 | 0.120 |
Why?
|
| Cataract | 1 | 2015 | 54 | 0.120 |
Why?
|
| Phenotype | 2 | 2011 | 1207 | 0.120 |
Why?
|
| Radiation Injuries | 1 | 2015 | 67 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 673 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 341 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1617 | 0.110 |
Why?
|
| Proteome | 1 | 2015 | 150 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 86 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 326 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 224 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 642 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2025 | 47 | 0.100 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2012 | 33 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 283 | 0.100 |
Why?
|
| Mice | 5 | 2017 | 10846 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2005 | 936 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2017 | 895 | 0.090 |
Why?
|
| Arabidopsis | 1 | 2012 | 83 | 0.090 |
Why?
|
| Schizosaccharomyces | 1 | 2012 | 105 | 0.090 |
Why?
|
| Cycloheximide | 1 | 2011 | 21 | 0.090 |
Why?
|
| Transcriptome | 1 | 2014 | 387 | 0.090 |
Why?
|
| Young Adult | 4 | 2025 | 4700 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 70 | 0.080 |
Why?
|
| Endopeptidases | 1 | 2010 | 67 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 67 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2010 | 99 | 0.080 |
Why?
|
| Protein Binding | 2 | 2005 | 1603 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 745 | 0.080 |
Why?
|
| Chromosomes | 1 | 2011 | 135 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1236 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2010 | 309 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2008 | 34 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 11 | 0.070 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2007 | 23 | 0.070 |
Why?
|
| Genes, Fungal | 1 | 2007 | 56 | 0.070 |
Why?
|
| Chromosomes, Fungal | 1 | 2007 | 35 | 0.070 |
Why?
|
| G1 Phase | 1 | 2007 | 56 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2008 | 260 | 0.070 |
Why?
|
| Adolescent | 3 | 2025 | 6248 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2008 | 136 | 0.070 |
Why?
|
| Prevalence | 2 | 2025 | 1383 | 0.060 |
Why?
|
| Actin-Related Protein 2 | 2 | 2003 | 6 | 0.060 |
Why?
|
| Actin-Related Protein 3 | 2 | 2003 | 6 | 0.060 |
Why?
|
| Temperature | 1 | 2007 | 307 | 0.060 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2005 | 8 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 7 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2005 | 21 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 2578 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2005 | 139 | 0.060 |
Why?
|
| Cattle | 1 | 2005 | 310 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 381 | 0.060 |
Why?
|
| Glucose | 1 | 2007 | 467 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2024 | 143 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 259 | 0.050 |
Why?
|
| Kinetics | 1 | 2005 | 763 | 0.050 |
Why?
|
| Universities | 1 | 2025 | 159 | 0.050 |
Why?
|
| Adult | 4 | 2025 | 16837 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2003 | 64 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 780 | 0.050 |
Why?
|
| Risk Factors | 2 | 2025 | 5359 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2022 | 64 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2024 | 622 | 0.050 |
Why?
|
| Polymers | 1 | 2005 | 325 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2003 | 385 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2022 | 68 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 1471 | 0.040 |
Why?
|
| Male | 4 | 2025 | 29927 | 0.040 |
Why?
|
| Female | 4 | 2025 | 32912 | 0.040 |
Why?
|
| Ornithine | 1 | 2017 | 24 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2017 | 33 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1256 | 0.030 |
Why?
|
| Arginine | 1 | 2017 | 124 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2003 | 3035 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Indonesia | 1 | 2015 | 19 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 866 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 673 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 174 | 0.030 |
Why?
|
| Retina | 1 | 2015 | 124 | 0.030 |
Why?
|
| Light | 1 | 2015 | 202 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 525 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 170 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2109 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 14472 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 334 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 17644 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2040 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5474 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 113 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 363 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2003 | 260 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2003 | 154 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 906 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1592 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1150 | 0.010 |
Why?
|